Rchr
J-GLOBAL ID：201501010851874820   Update date: Feb. 13, 2024

Kishi Taro

キシ タロウ | Kishi Taro
Affiliation and department：
Fujita Health University

About Fujita Health University


Other affiliations (1)：
  • 精神神経科学
Homepage URL  (1)： https://kaken.nii.ac.jp/d/r/40536801.ja.html
Research field  (1)： Psychiatry
Research keywords  (4)： エスシタロプラム ,  大うつ病性障害と ,  無作為割付試験 ,  パロキセチン徐放製剤
Research theme for competitive and other funds  (2)：
  • 2019 - 2024 Antipsychotic treatment and rehospitalization of schizophrenia patients: a cohort study
  • 2013 - 2015 fficacy and tolerability of escitalopram versus paroxetine-CR in Japanese patients with major depressive disorder: a randomized, masked-rater trial
Papers (240)：
  • Taro Kishi, Kenji Sakuma, Masakazu Hatano, Takenori Okumura, Masaki Kato, Hajime Baba, Nakao Iwata. Antidepressants available in Japan for older people with major depressive disorder: A systematic review and meta-analysis. Neuropsychopharmacology reports. 2024
  • Taro Kishi, Toshikazu Ikuta, Kenji Sakuma, Masakazu Hatano, Yuki Matsuda, Satoru Esumi, Nobumi Miyake, Itaru Miura, Masaki Kato, Nakao Iwata. Safety profile of antidepressant for Japanese adults with major depressive disorder: a systematic review and network meta-analysis. Psychiatry and clinical neurosciences. 2023
  • Yupeng He, Masaaki Matsunaga, Yuanying Li, Taro Kishi, Shinichi Tanihara, Nakao Iwata, Takahiro Tabuchi, Atsuhiko Ota. Classifying Schizophrenia Cases by Artificial Neural Network Using Japanese Web-Based Survey Data: Case-Control Study. JMIR Formative Research. 2023. 7. e50193-e50193
  • Shun Hamanaka, Taro Kishi, Kenji Sakuma, Yasufumi Nishii, Masakazu Hatano, Nakao Iwata. Serotonin 3 receptor antagonists for obsessive-compulsive disorder: A systematic review and pairwise meta-analysis. Journal of psychiatric research. 2023. 167. 132-138
  • Taro Kishi, Kenji Sakuma, Masakazu Hatano, Yuki Matsuda, Satoru Esumi, Nobumi Miyake, Itaru Miura, Hikaru Hori, Masaki Kato, Nakao Iwata. Newer antidepressant for Japanese adults with major depressive disorder: A systematic review and meta-analysis. Neuropsychopharmacology reports. 2023
ｍore...
MISC (147)：
  • 岡本直通, 渡邊啓太, 池ノ内篤子, 井形亮平, 小西勇輝, 手銭宏文, 夏山知也, 藤井倫太郎, 岸太郎, 岩田仲生, et al. 5-HTTLPRのs/s遺伝子型を持つ薬物未使用初発うつ病患者における扁桃体サブ領域体積と血中物質の関係:探索的研究. 日本神経化学会大会抄録集(Web). 2022. 65th
  • 岸太郎, 松田勇紀, 江角悟, 波多野正和, 三宅誕実, 佐久間健二, 橋本保彦, 川島邦裕, 宮原研吾. 向精神薬の適切な継続・減量・中止等の精神科薬物療法の出口戦略の実践に資する研究 マニュアル作成/双極性障害-気分安定薬. 向精神薬の適切な継続・減量・中止等の精神科薬物療法の出口戦略の実践に資する研究 令和2年度 総括・分担研究報告書(Web). 2021
  • 岸太郎, 江角悟, 大矢一登, 奥谷理, 佐久間健二, 野村郁雄, 橋本保彦, 波多野正和, 波多野正和, 松井佑樹, et al. Efficacy and safety of lithium and lamotrigine for the bipolar disorder in the maintenance phase: A systematic review and meta-analysis. 臨床精神薬理. 2021. 24. 9
  • Taro Kishi, Toshikazu Ikuta, Yuki Matsuda, Kenji Sakuma, Nakao Iwata. Aripiprazole vs. brexpiprazole for acute schizophrenia: a systematic review and network meta-analysis. Psychopharmacology. 2020. 237. 5. 1459-1470
  • Taro Kishi, Reiji Yoshimura, Yuki Matsuda, Kenji Sakuma, Nakao Iwata. Blonanserin patch vs. Other Antipsychotics for Acute Schizophrenia: A Systematic Review of Double-blind, Randomized, Placebo-controlled, Phase 3 Trials in Japan. Pharmacopsychiatry. 2020. 53. 3. 122-132
ｍore...
Professional career (1)：
  • 医学博士 (藤田保健衛生大学大学院)
Work history (1)：
  • 2018/04 - Fujita Health University School of Medicine
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM